Caris Life Sciences (CAI) Current Assets (2024 - 2026)

Caris Life Sciences has reported Current Assets for 3 years, with the latest figure at $1.1 billion in Q2 2026.

• On a quarterly basis, Current Assets rose 26.94% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 26.94% increase from a year earlier, with the FY2025 full-year figure at $997.8 million, up 362.52% from the prior year.
• Current Assets was $1.1 billion for Q2 2026 at Caris Life Sciences, up from $1.0 billion in the prior quarter.
• The five-year high for Current Assets was $1.1 billion in Q2 2026, with the low at $215.7 million in Q4 2024.
• Average Current Assets over 3 years is $828.9 million, with a median of $926.0 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Current Assets surged 362.52% in 2025, then climbed 26.94% in 2026.
• Over 3 years, Current Assets stood at $215.7 million in 2024, then soared by 362.52% to $997.8 million in 2025, then increased by 6.02% to $1.1 billion in 2026.
• The last three Current Assets figures came in at $1.1 billion (Q2 2026), $1.0 billion (Q1 2026), and $997.8 million (Q4 2025), per Business Quant data.